Partners

Carpmaels & Ransford

Website: https://www.carpmaels.com/

Carpmaels & Ransford LLP is a leader in the European IP market, having driven innovation in the industry for over 200 years. The firm advises clients on all aspects of intellectual property, including drafting, filing and prosecuting patent and trademark applications; drafting and negotiating licence agreements and other commercial IP agreements; advising on the transfer of property rights; assisting clients with patent restoration matters; and conducting enforcement and revocation litigation.

The firm has one of Europe’s largest IP teams serving blue-chip clients across the globe, including Johnson & Johnson, Bristol Myers Squibb, Novartis, Ionis Pharmaceuticals, Mars, Gilead, Raytheon, Regeneron, Takeda, Allergan and Xeros. The firm’s attorneys have considerable technical knowledge, bringing together experience from industry-leading companies, academic research at leading universities and extensive patent expertise in the areas of pharmaceuticals, biotechnology, engineering, tech, chemistry, materials, supplementary protection certificates and information and communication technologies and standards.

Through its fully integrated dispute resolution and transactions teams, the firm is able to provide a holistic service to clients which supports their IP needs from inception to commercialisation. The dispute resolution team, made up of experienced solicitors, barristers and patent attorney litigators, represents clients at all levels of the European Patent Office. The team is also adept at conducting enforcement litigation and revocation actions before the UK Intellectual Property Office and patent, copyright, trademark and other IP litigation in the English courts and the Court of Justice of the European Union, often advising in cases where parallel or related litigation is ongoing in courts across Europe or in the United States.

As a European IP firm with litigators and patent attorneys under one roof, Carpmaels & Ransford is looking forward to offering clients the chance to both obtain UPs using the existing EPO procedure and enforce their patents across Europe in the UPC.

Dechert

Website: https://www.dechert.com/

Gemini Law

Website: http://www.geminilaw.com/

Gemini attorneys are among the most experienced and successful at helping manufacturers of biopharma products navigate IP barriers to access the U.S. market. Gemini has particular expertise in patent strategy and litigation relating to biosimilar, biobetter, generic and 505(b)(2) products, as well as collateral issues concerning the Hatch Waxman and BPCIA regulatory schemes. Gemini is also very experienced in counseling early-stage biotech companies to optimize patent portfolios and mitigate the risk posed by competitors’ IP, as well as IP issues related to licensing and development transactions. Gemini offers “end to end” counseling on IP issues in support of biopharma product development and launch in the U.S., including: 

• Litigation risk mitigation and avoidance
• Patent & trade secret design-around strategies
• Patent portfolio optimization
• Biosimilar (BPCIA) litigation & regulatory strategy
• Hatch Waxman litigation & regulatory strategy
• "Biobetter" & "fast follow-on" product litigation & regulatory strategy
• Pharmaceutical device-related litigation & regulatory strategy
• IP & regulatory issues concerning healthcare AI
• CREATES Act requests & litigation
• Section 1782 discovery requests for use in foreign litigation
• Global coordination of litigation strategy concerning biosimilar, generic and biobetter products
• Patent landscaping and freedom-to-operate opinions
• IP-related licensing, development & manufacturing transactions
• Lobbying and legislative initiatives relating to the BPCIA and Hatch Waxman laws 

Hoffmann Eitle PartmbB

Website: https://www.hoffmanneitle.com/en

Licks

Website: https://www.lickslegal.com/

RNA LAW

Website: https://www.rna-law.com/

Simmons & Simmons

Website: https://www.simmons-simmons.com/en/expertise/service/intellectual-property/patents

Our international Patent team seamlessly integrates the specialized expertise of a boutique practice with the extensive service offerings of a major international firm. Recognized in the market for our high-calibre clients and active involvement in leading global patent cases, we stand as a trusted force in the European legal landscape; with offices and well established patent experts in London, Amsterdam, Paris, Munich and Milan and with Pharma & Biotech as one of our firm’s four core sectors.

Leveraging our extensive experience, we adeptly guide clients through specialised procedures, including infringement seizures, preliminary injunctions, patent infringement actions, patent nullification actions, and non-infringement declarations. With over 45 years at the forefront of IP law and practice, our international reputation is anchored in a pre-eminent track record in complex patent litigation (alongside a market-leading IP transactions and regulatory practices). Our comprehensive suite of services offers a "one-stop-shop" for pharma and biotech clients needing advice and strategic partnership on patents and other areas of IP.

Simmons and Simmons has played a pivotal role in the development of the Unified Patent Court (UPC) system. Our partner, Kevin Mooney, is acknowledged as one of the "fathers of the UPC", if not “Mr UPC”. Positioned at the forefront of every aspect of the new system, we don't just advise on the law – we actively shape it.

Sterne Kessler

Website: https://www.sternekessler.com/

Sterne, Kessler, Goldstein & Fox is a full-service intellectual property law firm that provides innovative solutions tailored to your business and industry. Since our founding in 1978, we have grown to become one of the largest IP specialty law firms in the United States. We collaborate across the full spectrum of IP to deliver real results for our clients—from patent and trademark prosecution, to patent litigation in federal district and appellate courts, strategic IP counseling, due diligence, and post-grant proceedings before the Patent Trial and Appeal Board.

Our team includes attorneys, patent agents, and technical specialists with 100+ advanced degrees, including 60+ Ph.D.s,, in science and engineering disciplines. We work with the world’s leading innovators and brands, ranging from individual inventors and startups to renowned universities and Fortune 500 companies.

We are proud to be one of the most highly regarded IP specialty law firms, and we have cultivated an environment that is welcoming, inclusive, and intellectually stimulating. And we’re honored that our attorneys and staff have voted Sterne Kessler as a Washington Post “Top Workplace” for 10 years running.

Venable LLP

Website: https://www.venable.com/

Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, high-net-worth entrepreneurs, and other individuals. With more than 850 professionals across the country, including in California, Colorado, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the United States and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit https://www.venable.com/